Fintel reports that on February 14, 2025, Evercore ISI Group upgraded their outlook for CRISPR Therapeutics (NasdaqGM:CRSP) from In-Line to Outperform. Analyst Price Forecast Suggests 90.46% Upside As ...

Welcome to ETF IQ, a weekly newsletter dedicated to the $14 trillion global ETF industry. I'm Bloomberg News reporter and anchor.

The expansion of private credit and increased private equity hold times have led to a surge in creative solutions to get capital back to investors.

A previous version of this report overstated the dollar amount and percentage of total assets allocated to private credit by U.S. Bancorp. The data source has revised its figures, and this story has ...

With an ever-growing list of similar-sounding funds to choose from, finding the best is an increasingly difficult task.

PDI, a closed-end fund managed by PIMCO, offers a robust 13.5% dividend yield and is well-positioned for the coming rate ...

The International Energy Agency (IEA) says in a new report, that “global electricity use is forecast to rise significantly in the coming years ...

While noting that further measures to revive the exchange have yet to be announced, Citi analyst Tan Yong Hong in a Feb 13 ...

Velvet Capital founder Vasily Nikonov argues that the collapse of crypto lending platforms like Celsius wasn’t just about bad debts.

Sign up here to get MarketWatch's highlights of the most timely ETF news emailed to you weekly! The S&P 500 pushed through its trading range - but can the bulls hold the line? 20 stocks of companies ...

We recently published a list of 10 Best Major Stocks to Buy According to Hedge Funds. In this article, we are going to take a ...

A hedge fund startup that uses artificial intelligence to do work typically handled by analysts has outperformed the global ...